Literature DB >> 35315214

Record high parainfluenza season in children after relaxation of COVID-19 restrictions in fall 2021-A nationwide register study in Finland.

Ilari Kuitunen1,2, Miia Artama3,4, Marjut Haapanen1, Marjo Renko1,5.   

Abstract

Social restrictions interrupted the circulation of common respiratory viruses among children in spring 2020. In the winter season 2020-2021, only rhinovirus spread in Finland. As the restrictions were ended in September 2021, we saw record high epidemic peak of parainfluenza. Typically, the epidemic peak is in springtime, but now, it started in the early fall 2021. The monthly incidence among children aged 0-4 years (120 per 100,000 children) was six times higher than the second highest reported monthly incidence (21 per 100,000 children) during the last 10 years. Our finding highlights the importance of active surveillance of viral respiratory pathogens during the pandemic.
© 2022 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; RSV; adenovirus; influenza; parainfluenza; rhinovirus

Mesh:

Year:  2022        PMID: 35315214      PMCID: PMC9111305          DOI: 10.1111/irv.12983

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   5.606


BACKGROUND

Social restrictions set against COVID‐19 reduced the circulation of common respiratory pathogens rapidly among children in Finland in spring 2020. , This was seen in all common respiratory viruses (influenza A and B, parainfluenza, respiratory syncytial virus [RSV] and rhinovirus), resulting in lower pediatric emergency department visit rates. , As the schools were reopened, rhinovirus started to spread normally. , There have been minimal restrictions towards children after May 2020 in Finland, and masking has not been promoted for children aged less than 12 years at any point. Despite the relaxed restrictions, Finland did not have RSV or influenza season in winter 2020–2021 at all, , although rhinovirus spread normally. Pediatric emergency department visit rates returned to normal level already during the summer 2020. As the last restrictions were abandoned in fall 2021, we saw an increasing trend in the emergency department visits and hospitalizations due to respiratory symptoms in the youngest children (age 0–4 years). Timing of this early epidemic was prior to traditional RSV season and rhinovirus detections remained in normal levels. Based on the preliminary infectious diseases' surveillance, parainfluenza seemed to be overrepresented in fall 2021. Previous studies from the USA noted that parainfluenza detections turned to increase in spring 2021 after being in record low levels in 2020. Therefore, we decided to examine the epidemiology of parainfluenza virus infections in Finnish children during the last 10 years and focused especially to the pandemic era.

MATERIALS

We conducted a nationwide register‐based retrospective epidemiologic surveillance study. We included all laboratory confirmed parainfluenza virus findings from the National Infectious Diseases Register from January 2012 to December 2021. We included children aged 0–14 and stratified them into three groups (0–4, 5–9, and 10–14 years old). We calculated weekly and monthly incidences per 100,000 children in each age group. The National Infectious Diseases Register contains all microbiological findings, and all laboratories in Finland are mandated by the law of contagious diseases to report findings of notifiable diseases immediately to the register, which is maintained by the Finnish Institute of Health and Welfare. The coverage of the register is excellent. Due to the fully register‐based study design, our study did not need ethical committee evaluation or study permission.

RESULTS

We included a total of 3,887 parainfluenza virus detections during our study period (2012–2021), and majority of these (81%) were detected in the youngest age group (age 0–4 years). In the monthly comparison, the incidences remained relatively stable between years until the beginning of the pandemic in March 2020 (Figure 1). Typically, the incidence peaks have been in the spring. During the year 2020, the weekly incidences remained near to zero until the detections were noted from the beginning of year 2021 again. The incidence turned to rapid increase after summer holidays in fall 2021, and this was seen all age groups (Figure 2). The incidence peak was six times higher than any previous peak in the last 10 years (Figure 1). Highest recorded weekly incidence (35 per 100,000) was reported in week 41 of 2021. The peak in 2021 was rapid, and the incidence turned immediately to rapid decline, which has been seen in previous incidence peak as well.
FIGURE 1

Monthly incidences of laboratory confirmed parainfluenza virus findings per 100,000 children stratified by age (0–4, 5–9, and 10–14 years) in Finland from January 2012 to December 2021

FIGURE 2

Weekly incidences of parainfluenza virus findings per 100,000 children stratified by age (0–4, 5–9, and 10–14 years) in Finland from 2018 to 2021

Monthly incidences of laboratory confirmed parainfluenza virus findings per 100,000 children stratified by age (0–4, 5–9, and 10–14 years) in Finland from January 2012 to December 2021 Weekly incidences of parainfluenza virus findings per 100,000 children stratified by age (0–4, 5–9, and 10–14 years) in Finland from 2018 to 2021

DISCUSSION

We report a record epidemic of parainfluenza virus detections among Finnish children after the relaxation of social restrictions in fall 2021. The peak occurred in atypical season, as traditionally the parainfluenza peak is observed in the spring. Similar atypical peaks have been reported with rhinoviruses and RSV in Asia, Australia, Europe, and the USA after the relaxation of social restrictions. , , , , We did not find any relevant reports outside the USA on the possible parainfluenza resurgence after the restrictions were relaxed. Our findings highlight the importance of active pathogen surveillance during a pandemic. Majority of the testing resources have been used to test COVID‐19, but we should also recognize other pathogens. In Finland, respiratory viruses are typically tested in pediatric emergency rooms from patients needing inpatient admissions. The testing guideline regarding the use of broader viral sampling has not changed during the COVID‐19 pandemic, although a limitation to our results is the lack of nationwide testing rates as it is not reported to the National Infectious Diseases Register. Furthermore, we lack the hospital data, so we are unable to analyze the clinical spectrum of this record high parainfluenza season. Our main strength is the nationwide register, where all laboratories are mandated by the law of contagious diseases to report all positive findings of notifiable diseases. This allows us to calculate precise nationwide incidence estimates. In conclusion, we report a record high parainfluenza virus season in Finnish children during the fall 2021. The epidemic peak occurred immediately after the social restrictions were ended in Finland. Our finding highlights the need for active disease surveillance during the pandemic.

AUTHOR CONTRIBUTIONS

Ilari Kuitunen: Conceptualization; formal analysis; investigation; methodology; software; visualization. Miia Artama: Conceptualization; data curation; project administration; resources. Marjut Haapanen: Investigation; methodology; visualization. Marjo Renko: Conceptualization; funding acquisition; project administration; resources; supervision.

PEER REVIEW

The peer review history for this article is available at https://publons.com/publon/10.1111/irv.12983.
  13 in total

1.  Lessons to learn from the current pandemic for future non-pharmaceutical interventions against the respiratory syncytial virus - nationwide register-study in Finland.

Authors:  Ilari Kuitunen; Marjo Renko
Journal:  Infect Dis (Lond)       Date:  2021-03-08

2.  Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis.

Authors:  Ana Isabel Reyes Domínguez; Svetlana Pavlovic Nesic; Lourdes Urquía Martí; María Del Carmen Pérez González; Desiderio Reyes Suárez; Fermín García-Muñoz Rodrigo
Journal:  Paediatr Perinat Epidemiol       Date:  2022-01-04       Impact factor: 3.980

3.  The impact of the lockdown and the re-opening of schools and day cares on the epidemiology of SARS-CoV-2 and other respiratory infections in children - A nationwide register study in Finland.

Authors:  Marjut Haapanen; Marjo Renko; Miia Artama; Ilari Kuitunen
Journal:  EClinicalMedicine       Date:  2021-03-29

4.  Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia.

Authors:  David Anthony Foley; Linny Kimly Phuong; Joseph Peplinski; Selina Mei Lim; Wei Hao Lee; Asifa Farhat; Cara A Minney-Smith; Andrew C Martin; Ariel O Mace; Chisha T Sikazwe; Huong Le; Avram Levy; Tobias Hoeppner; Meredith L Borland; Briony Hazelton; Hannah C Moore; Christopher Blyth; Daniel K Yeoh; Asha C Bowen
Journal:  Arch Dis Child       Date:  2021-08-25       Impact factor: 3.791

5.  Influenza and respiratory syncytial virus during the COVID-19 pandemic: Time for a new paradigm?

Authors:  Emma Binns; Marianne Koenraads; Lidia Hristeva; Alix Flamant; Sebastian Baier-Grabner; Mervin Loi; Johanna Lempainen; Elise Osterheld; Bazlin Ramly; Jessica Chakakala-Chaziya; Niveditha Enaganthi; Silvia Simó Nebot; Danilo Buonsenso
Journal:  Pediatr Pulmonol       Date:  2021-10-13

6.  COVID-19 restrictions probably brought the 2019-2020 Finnish influenza season to an early end and led to fewer respiratory viruses among infants.

Authors:  Sallamaria Kelloniemi; Paula Heikkilä; Sauli Palmu
Journal:  Acta Paediatr       Date:  2021-08-12       Impact factor: 4.056

7.  Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions-A nationwide register study in Finland.

Authors:  Ilari Kuitunen; Miia Artama; Marjut Haapanen; Marjo Renko
Journal:  J Med Virol       Date:  2021-07-06       Impact factor: 2.327

8.  Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021.

Authors:  Sonja J Olsen; Amber K Winn; Alicia P Budd; Mila M Prill; John Steel; Claire M Midgley; Krista Kniss; Erin Burns; Thomas Rowe; Angela Foust; Gabriela Jasso; Angiezel Merced-Morales; C Todd Davis; Yunho Jang; Joyce Jones; Peter Daly; Larisa Gubareva; John Barnes; Rebecca Kondor; Wendy Sessions; Catherine Smith; David E Wentworth; Shikha Garg; Fiona P Havers; Alicia M Fry; Aron J Hall; Lynnette Brammer; Benjamin J Silk
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-07-23       Impact factor: 17.586

9.  Closing Finnish schools and day care centres had a greater impact on primary care than secondary care emergency department visits.

Authors:  Ilari Kuitunen; Marjut Haapanen; Miia Artama; Marjo Renko
Journal:  Acta Paediatr       Date:  2020-11-11       Impact factor: 4.056

View more
  5 in total

1.  Unusual late epidemic peak during influenza season 2021-2022: A nationwide register-based analysis in Finland.

Authors:  Ilari Kuitunen; Marjo Renko; Terhi Tapiainen
Journal:  Influenza Other Respir Viruses       Date:  2022-09-01       Impact factor: 5.606

Review 2.  Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020-2021.

Authors:  Chiara Achangwa; Huikyung Park; Sukhyun Ryu; Moo-Sik Lee
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

3.  Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Findings in Children During COVID-19 Pandemic in Finland.

Authors:  Ilari Kuitunen
Journal:  SN Compr Clin Med       Date:  2022-07-14

4.  Respiratory virus circulation in children after relaxation of COVID-19 restrictions in fall 2021-A nationwide register study in Finland.

Authors:  Ilari Kuitunen; Miia Artama; Marjut Haapanen; Marjo Renko
Journal:  J Med Virol       Date:  2022-05-23       Impact factor: 20.693

5.  Seasonal epidemiological and clinical characteristics of pediatric patients with human parainfluenza virus infection by serotype: a retrospective study.

Authors:  Ji Yoon Han; Woosuck Suh; Seung Beom Han
Journal:  Virol J       Date:  2022-09-06       Impact factor: 5.913

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.